Associated Papers
Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncology.
Kerle IA et al.
Npj Precision Oncology, 2025
39794422 (PubMed )
Supplement: 41698_2024_788_MOESM7_ESM.xlsx › patient_10_panel_small_variants
Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes.
Soukupova J et al.
Plos One, 2018
29649263 (PubMed )
Supplement: pone.0195761.s003.xlsx › S3
Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
Määttä KM et al.
Bmc Cancer, 2017
Identification of an aggressive prostate cancer predisposing variant at 11q13.
Nurminen R et al.
International Journal of Cancer, 2011
Select a paper to view details